SCHEMBL5962395

SCHEMBL5962395

CC(C)Sc1ncccc1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
GAA P10253 2/20 0.55
TDP1 Q9NUW8 2/20 0.54
MAPT P10636 2/20 0.54
CYP2C9 P11712 1/20 0.54
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
TP53 P04637 1/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
KDM4E B2RXH2 2/20 0.52
PKM P14618 1/20 0.51
LMNA P02545 1/20 0.51
HSD17B10 Q99714 1/20 0.51
EGLN1 Q9GZT9 1/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
BLM P54132 1/20 0.50
AGER Q15109 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833175 0.85 PARP1 (0.47) ALDH1A1SMN1; SMN2GAATDP1MAPT
SCHEMBL15669275 0.84 MAPT (0.60) ALDH1A1SMN1; SMN2GAATDP1MAPT
SCHEMBL31328134 0.83 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2GAATDP1MAPT
SCHEMBL4023273 0.82 TDP1 (0.48) ALDH1A1SMN1; SMN2GAATDP1MAPT
SCHEMBL355357 0.80 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2GAATDP1MAPT
SCHEMBL146157 0.80 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2GAATDP1MAPT
SCHEMBL15668691 0.79 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2GAACYP2C9NPC1
Hydrochloric Acid SCHEMBL1375604 0.79 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2GAATDP1MAPT
SCHEMBL2750439 0.78 SMN1; SMN2 (0.63) ALDH1A1SMN1; SMN2GAATDP1MAPT
SCHEMBL11504619 0.78 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2GAATDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2914580-B1 THIOARYL DERIVATIVES AS GPR120 AGONISTS LG CHEMICAL LTD (KR) 2019-02-20 EP disclosed
US-9447044-B2 Thioaryl derivatives as GPR120 agonists LG LIFE SCIENCES LTD. (KR) 2016-09-20 US disclosed
US-20150291527-A1 THIOARYL DERIVATIVES AS GPR120 AGONISTS LG LIFE SCIENCES LTD. (KR) 2015-10-15 US disclosed
EP-2914580-A1 THIOARYL DERIVATIVES AS GPR120 AGONISTS LG Life Sciences Ltd. (KR) 2015-09-09 EP disclosed
WO-2014069963-A1 THIOARYL DERIVATIVES AS GPR120 AGONISTS LG LIFE SCIENCES LTD. (KR) 2014-05-08 WO disclosed
US-8304451-B2 Histone deacetylase and tubulin deacetylase inhibitors PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-11-06 US disclosed
US-8304451-B2 Histone deacetylase and tubulin deacetylase inhibitors PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-11-06 US disclosed
US-8178579-B2 Histone deacetylase inhibitors; anticancer agents; antiprotozoa agents PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-05-15 US disclosed
US-20090209590-A1 Histone Deacetylase and Tubulin Deacetylase Inhibitors PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2009-08-20 US disclosed
US-20090209590-A1 Histone Deacetylase and Tubulin Deacetylase Inhibitors PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2009-08-20 US disclosed
US-20080269245-A1 Dioxanes and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2008-10-30 US disclosed
WO-2007095584-A2 Histone Deacetylase Inhibitors THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2007-08-23 WO disclosed
US-7244853-B2 Dioxanes and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2007-07-17 US disclosed
US-20040072849-A1 Dioxanes and uses thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-04-15 US disclosed
EP-0558445-A1 Sulfonylureas as herbicides CIBA-GEIGY AG (CH) 1993-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291527-A1 THIOARYL DERIVATIVES AS GPR120 AGONISTS GPR119, GLP1R, GCGR ALDH1A1 1822/4885SMN1; SMN2 4477/4885GAA 2413/4885
US-20090209590-A1 Histone Deacetylase and Tubulin Deacetylase Inhibitors HDAC6, HDAC1, HDAC5 ALDH1A1 320/4885SMN1; SMN2 3990/4885GAA 440/4885
US-20040072849-A1 Dioxanes and uses thereof UTS2R, HDAC5, AMDHD2 ALDH1A1 682/4885SMN1; SMN2 3947/4885GAA 220/4885
US-20080269245-A1 Dioxanes and uses thereof UTS2R, MAN2B2, AMDHD2 ALDH1A1 750/4885SMN1; SMN2 3819/4885GAA 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.